Clinical Trials

Our mission is to empower women to be proactive with their breast health by providing the latest technology, the best knowledge, and we’d like to think, a pretty unique experience. This starts right at the beginning with our clinical trials.

The QT Ultrasound Breast scanner is a new kind of whole breast ultrasound device, with FDA clearance as an adjunct to mammography, that scans the breast without radiation, compression, or injection.  Our goal is to provide more accurate and holistic results, and that's why we recruit volunteers, like yourself, to take part in our clinical trials so that we may continue to evaluate the efficacy of our ultrasound technology. The process is easy, safe, pain free, and gives women the opportunity to help women, and advance breast imaging technology. 

Ready to become part of something big? Consider volunteering for one of our upcoming clinical trials.


Trial 1

Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging

Enrollment status: Recruiting

Clinicaltrials.gov

Group A: Comparing QT Ultrasound with traditional mammography

  • Healthy female 40 and over, who will undergo screening mammography as well as a QTscan.

Group B: Comparing QT Ultrasound with traditional mammography for women with recommendation for biopsy

  • Female over age 25 who has recommendation to undergo biopsy based on prior mammogram and/or ultrasound. (ie. Bi-Rads 4 or 5)
  • A finding that was not felt and only discovered on screening

Group C: Using QT Ultrasound in women that do not fit into Group A or B based on their most recent standard of care assessment

  • Female over age 18 who are eligible for mammography based on current ACR guidelines 


Trial 2

Clinical Product Development Studying the QT Ultrasound® Breast Scanner with Volunteer Subjects

Enrollment Status: This study is enrolling participants by invitation only.

Clinicaltrials.gov

NIH Grant

  • Female 18 and over, who will undergo a QTscan

Trial 3

STUDY IN THE EVALUATION OF DOUBLING TIME RATES IN NON-SUSPICIOUS BREAST MASSES USING QT ULTRASOUND TECHNOLOGY

Enrollment Status: Recruiting             

Clinicaltrials.gov

Group A: Collecting (2) QTscans between 90 and 180 days apart prior to breast biopsy and a final QTscan 12 months from the initial QTscan

  • Female over age 18 who has been asked to follow-up a non-suspicious lesion as seen on standard breast imaging (ie. Bi-Rads 3)

Group B: Collecting a QTscan prior to or immediately following a breast biopsy followed by a QTscan collected between 90 and 180 days from breast biopsy and a final QTscan 12 months from breast biopsy

  • Female over age 18 who has been advised to have or may have already had a standard of care breast biopsy of a non-suspicious lesion as seen on standard breast imaging (ie. Fibroadenoma)
  • Enrolled subjects who have not yet had a biopsy, may qualify to receive a baseline QTscan prior to the biopsy
  • Subjects who have already had a breast biopsy, prior to enrollment but no longer than 30 days after biopsy, may undergo a QTscan after the biopsy

 

 

To join our mailing list
for updates on new developments and future trials, sign up here.

Name *
Name
Phone
Phone

If you don’t qualify for one of our research studies, visit QTbreasthealth for information on how to schedule a QTscan at one of our scanning centers.